Publications

  1. Bharucha AE, Kudva Y, Basu A, Camilleri M, Low PA, Vella A, Zinsmeister AR. Relationship Between Glycemic Control and Gastric Emptying In Poorly Controlled Type 2 Diabetes. Clin Gastroenterol Hepatol. 2014 Jul 17.
    View PubMed
  2. Hames KC, Vella A, Kemp BJ, Jensen MD. Free Fatty Acid Uptake in Humans with CD36 Deficiency. Diabetes. 2014 Jun 10.
    View PubMed
  3. Shah M, Vella A. Effects of GLP-1 on appetite and weight. Rev Endocr Metab Disord. 2014 May 09.
    View PubMed
  4. Nair KS, Abel ED, Adler SG, Dyck PJ, Gardner TW, Haskins KM, Hotamisligil G, Jensen MD, Krook A, Mandarino LJ, Mitchell BD, Pessin JE, Sowers JR, Sussel L, Wareham N, Vella A. Time to look back and to look forward. Diabetes. 2014 Apr; 63(4):1169-70.
    View PubMed
  5. Shah M, Law JH, Micheletto F, Sathananthan M, Dalla Man C, Cobelli C, Rizza RA, Camilleri M, Zinsmeister AR, Vella A. Contribution of endogenous glucagon-like peptide 1 to glucose metabolism after Roux-en-Y gastric bypass. Diabetes. 2014 Feb; 63(2):483-93. Epub 2013 Oct 02.
    View PubMed
  6. Ikramuddin S, Korner J, Lee WJ, Connett JE, Inabnet WB, Billington CJ, Thomas AJ, Leslie DB, Chong K, Jeffery RW, Ahmed L, Vella A, Chuang LM, Bessler M, Sarr MG, Swain JM, Laqua P, Jensen PD, Bantle JP. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia. Diabetes Technology and Therapeutics. 2014; 16(Suppl 1):S79-80.
  7. Cobelli C, Man CD, Toffolo G, Basu R, Vella A, Rizza R. The oral minimal model method. Diabetes. 2014; 63(4):1203-13.
  8. Sathananthan M, Ikramuddin S, Swain JM, Shah M, Piccinini F, Dalla Man C, Cobelli C, Rizza RA, Camilleri M, Vella A. The effect of vagal nerve blockade using electrical impulses on glucose metabolism in nondiabetic subjects. Diabetes Metab Syndr Obes. 2014; 7:305-12. Epub 2014 Jul 11.
    View PubMed
  9. Shin A, Camilleri M, Busciglio I, Burton D, Smith SA, Vella A, Ryks M, Rhoten D, Zinsmeister AR. The ghrelin agonist RM-131 accelerates gastric emptying of solids and reduces symptoms in patients with type 1 diabetes mellitus. Clin Gastroenterol Hepatol. 2013 Nov; 11(11):1453-1459.e4. Epub 2013 Apr 30.
    View PubMed
  10. Prutsky GJ, Domecq JP, Sundaresh V, Elraiyah T, Nabhan M, Prokop LJ, Vella A, Montori VM, Murad MH. Screening for gestational diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2013 Nov; 98(11):4311-8. Epub 2013 Oct 22.
    View PubMed
  11. Prutsky GJ, Domecq JP, Wang Z, Carranza Leon BG, Elraiyah T, Nabhan M, Sundaresh V, Vella A, Montori VM, Murad MH. Glucose targets in pregnant women with diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2013 Nov; 98(11):4319-24. Epub 2013 Oct 22.
    View PubMed
  12. Sathananthan M, Farrugia LP, Miles JM, Piccinini F, Dalla Man C, Zinsmeister AR, Cobelli C, Rizza RA, Vella A. Direct effects of exendin-(9,39) and GLP-1-(9,36)amide on insulin action, beta-cell function, and glucose metabolism in nondiabetic subjects. Diabetes. 2013 Aug; 62(8):2752-6. Epub 2013 Apr 01.
    View PubMed
  13. Ikramuddin S, Korner J, Lee WJ, Connett JE, Inabnet WB, Billington CJ, Thomas AJ, Leslie DB, Chong K, Jeffery RW, Ahmed L, Vella A, Chuang LM, Bessler M, Sarr MG, Swain JM, Laqua P, Jensen MD, Bantle JP. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA. 2013 Jun 5; 309(21):2240-9.
    View PubMed
  14. Ketha S, Smithedajkul P, Vella A, Pruthi R, Wysokinski W, McBane R. Adrenal haemorrhage due to heparin-induced thrombocytopenia. Thromb Haemost. 2013 Apr; 109(4):669-75. Epub 2013 Feb 07.
    View PubMed
  15. Smushkin G, Sathananthan M, Piccinini F, Dalla Man C, Law JH, Cobelli C, Zinsmeister AR, Rizza RA, Vella A. The effect of a bile acid sequestrant on glucose metabolism in subjects with type 2 diabetes. Diabetes. 2013 Apr; 62(4):1094-101. Epub 2012 Dec 18.
    View PubMed
  16. Donegan DM, Vella A. 69-year-old man with recurrent episodes of confusion and diaphoresis. Mayo Clin Proc. 2013 Apr; 88(4):410-3.
    View PubMed
  17. Shin A, Camilleri M, Busciglio I, Burton D, Stoner E, Noonan P, Gottesdiener K, Smith SA, Vella A, Zinsmeister AR. Randomized controlled phase Ib study of ghrelin agonist, RM-131, in type 2 diabetic women with delayed gastric emptying: pharmacokinetics and pharmacodynamics. Diabetes Care. 2013 Jan; 36(1):41-8. Epub 2012 Sep 06.
    View PubMed
  18. Vella A. Enteroendocrine secretion after Roux-en-Y gastric bypass: is it important? Neurogastroenterol Motil. 2013 Jan; 25(1):1-3.
    View PubMed
  19. Vella A, Kumar R. Osteocalcin and the regulation of glucose metabolism. Clinical Reviews in Bone and Mineral Metabolism. 2013; 11(1):11-6.
  20. Dyck PJ, Overland CJ, Low PA, Litchy WJ, Davies JL, Dyck PJ, Carter RE, Melton LJ, Andersen H, Albers JW, Bolton CF, England JD, Klein CJ, Llewelyn G, Mauermann ML, Russell JW, Selvarajah D, Singer W, Smith AG, Tesfaye S, Vella A. "Unequivocally Abnormal" vs "Usual" Signs and Symptoms for Proficient Diagnosis of Diabetic Polyneuropathy: Cl vs N Phys Trial. Arch Neurol. 2012 Dec; 69(12):1609-14.
    View PubMed
  21. Smushkin G, Sathananthan M, Sathananthan A, Dalla Man C, Micheletto F, Zinsmeister AR, Cobelli C, Vella A. Diabetes-associated common genetic variation and its association with GLP-1 concentrations and response to exogenous GLP-1. Diabetes. 2012 May; 61(5):1082-9. Epub 2012 Mar 28.
    View PubMed
  22. Erickson D, Singh RJ, Sathananthan A, Vella A, Bryant SC. Late-night salivary cortisol for diagnosis of Cushing's syndrome by liquid chromatography/tandem mass spectrometry assay. Clin Endocrinol (Oxf). 2012 Apr; 76(4):467-72.
    View PubMed
  23. Smushkin G, Sathananthan A, Man CD, Zinsmeister AR, Camilleri M, Cobelli C, Rizza RA, Vella A. Defects in GLP-1 response to an oral challenge do not play a significant role in the pathogenesis of prediabetes. J Clin Endocrinol Metab. 2012 Feb; 97(2):589-98. Epub 2011 Nov 16.
    View PubMed
  24. Sathananthan A, Dalla Man C, Zinsmeister AR, Camilleri M, Rodeheffer RJ, Toffolo G, Cobelli C, Rizza RA, Vella A. A concerted decline in insulin secretion and action occurs across the spectrum of fasting and postchallenge glucose concentrations. Clin Endocrinol (Oxf). 2012 Feb; 76(2):212-9.
    View PubMed
  25. Levy MJ, Thompson GB, Topazian MD, Callstrom MR, Grant CS, Vella A. US-guided ethanol ablation of insulinomas: a new treatment option. Gastrointest Endosc. 2012 Jan; 75(1):200-6. Epub 2011 Nov 10.
    View PubMed
  26. Singh E, Vella A. Hypoglycemia after gastric bypass surgery. Diabetes Spectrum. 2012; 25(4):217-21.
  27. Vazquez-Roque MI, Camilleri M, Vella A, Carlson P, Laugen J, Zinsmeister AR. Association of genetic variation in cannabinoid mechanisms and gastric motor functions and satiation in overweight and obesity. Neurogastroenterol Motil. 2011 Jul; 23(7):637-e257. Epub 2011 Apr 07.
    View PubMed
  28. Vazquez-Roque MI, Camilleri M, Vella A, Carlson P, Laugen J, Zinsmeister AR. Association of TCF7L2 allelic variations with gastric function, satiation, and GLP-1 levels. Clin Transl Sci. 2011 Jun; 4(3):183-7.
    View PubMed
  29. Kumar R, Vella A. Carbohydrate metabolism and the skeleton: picking a bone with the beta-cell. J Clin Endocrinol Metab. 2011 May; 96(5):1269-71. Epub 2011 Feb 23.
    View PubMed
  30. Richards ML, Thompson GB, Farley DR, Kendrick ML, Service JF, Vella A, Grant CS. Setting the bar for laparoscopic resection of sporadic insulinoma. World J Surg. 2011 Apr; 35(4):785-9.
    View PubMed
  31. Kumar R, Binkley N, Vella A. Effect of phylloquinone supplementation on glucose homeostasis in humans. Am J Clin Nutr. 2010 Dec; 92(6):1528-32. Epub 2010 Sep 29.
    View PubMed
  32. Vanderveen KA, Grant CS, Thompson GB, Farley DR, Richards ML, Vella A, Vollrath B, Service FJ. Outcomes and quality of life after partial pancreatectomy for noninsulinoma pancreatogenous hypoglycemia from diffuse islet cell disease. Surgery. 2010 Dec; 148(6):1237-45; discussion 1245-6.
    View PubMed
  33. Smushkin G, Vella A. What is type 2 diabetes? Medicine (Abingdon). 2010 Nov 1; 38(11):597-601.
    View PubMed
  34. Benavente-Chenhalls LA, Vella A, Farley DR, Thompson GB, Grant CS, Richards ML. Malignant adrenal neoplasm masquerading as worrisome adrenal hemorrhage. Ann Surg Oncol. 2010 Oct; 17(10):2710-3. Epub 2010 May 25.
    View PubMed
  35. Sathananthan A, Man CD, Micheletto F, Zinsmeister AR, Camilleri M, Giesler PD, Laugen JM, Toffolo G, Rizza RA, Cobelli C, Vella A. Common genetic variation in GLP1R and insulin secretion in response to exogenous GLP-1 in nondiabetic subjects: a pilot study. Diabetes Care. 2010 Sep; 33(9):2074-6.
    View PubMed
  36. Dyck PJ, Overland CJ, Low PA, Litchy WJ, Davies JL, Dyck PJ, O'Brien PC, Cl vs. NPhys Trial Investigators, Albers JW, Andersen H, Bolton CF, England JD, Klein CJ, Llewelyn JG, Mauermann ML, Russell JW, Singer W, Smith AG, Tesfaye S, Vella A. Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trial. Muscle Nerve. 2010 Aug; 42(2):157-64.
    View PubMed
  37. Bock G, Dalla Man C, Micheletto F, Basu R, Giesler PD, Laugen J, Deacon CF, Holst JJ, Toffolo G, Cobelli C, Rizza RA, Vella A. The effect of DPP-4 inhibition with sitagliptin on incretin secretion and on fasting and postprandial glucose turnover in subjects with impaired fasting glucose. Clin Endocrinol (Oxf). 2010 Aug; 73(2):189-96. Epub 2009 Dec 18.
    View PubMed
  38. Smushkin G, Vella A. Genetics of type 2 diabetes. Curr Opin Clin Nutr Metab Care. 2010 Jul; 13(4):471-7.
    View PubMed
  39. Erickson D, Erickson B, Watson R, Patton A, Atkinson J, Meyer F, Nippoldt T, Carpenter P, Natt N, Vella A, Thapa P. 3 Tesla magnetic resonance imaging with and without corticotropin releasing hormone stimulation for the detection of microadenomas in Cushing's syndrome. Clin Endocrinol (Oxf). 2010 Jun; 72(6):793-9. Epub 2009 Oct 07.
    View PubMed
  40. Dalla Man C, Micheletto F, Sathananthan A, Rizza RA, Vella A, Cobelli C. A model of GLP-1 action on insulin secretion in nondiabetic subjects. Am J Physiol Endocrinol Metab. 2010 Jun; 298(6):E1115-21. Epub 2010 Feb 23.
    View PubMed
  41. Papathanasopoulos A, Camilleri M, Carlson PJ, Vella A, Nord SJ, Burton DD, Odunsi ST, Zinsmeister AR. A preliminary candidate genotype-intermediate phenotype study of satiation and gastric motor function in obesity. Obesity (Silver Spring). 2010 Jun; 18(6):1201-11. Epub 2009 Oct 29.
    View PubMed
  42. Vella A, Rizza RA. Application of isotopic techniques using constant specific activity or enrichment to the study of carbohydrate metabolism. Diabetes. 2009 Oct; 58(10):2168-74.
    View PubMed
  43. Samsom M, Bharucha A, Gerich JE, Herrmann K, Limmer J, Linke R, Maggs D, Schirra J, Vella A, Worle HJ, Goke B. Diabetes mellitus and gastric emptying: questions and issues in clinical practice. Diabetes Metab Res Rev. 2009 Sep; 25(6):502-14.
    View PubMed
  44. Sathananthan A, Vella A. Personalized pharmacotherapy for Type 2 diabetes mellitus. Per Med. 2009 Jul 1; 6(4):417-422.
    View PubMed
  45. Vella A. Pharmacogenetics for type 2 diabetes: practical considerations for study design. J Diabetes Sci Technol. 2009 Jul; 3(4):705-9. Epub 2009 Jul 01.
    View PubMed
  46. Brown DL, Henrichsen TL, Clayton AC, Hudson SB, Coddington CC 3rd, Vella A. Ovarian stromal hyperthecosis: sonographic features and histologic associations. J Ultrasound Med. 2009 May; 28(5):587-93.
    View PubMed
  47. Placzkowski KA, Vella A, Thompson GB, Grant CS, Reading CC, Charboneau JW, Andrews JC, Lloyd RV, Service FJ. Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987-2007. J Clin Endocrinol Metab. 2009 Apr; 94(4):1069-73. Epub 2009 Jan 13.
    View PubMed
  48. Rumilla KM, Erickson LA, Service FJ, Vella A, Thompson GB, Grant CS, Lloyd RV. Hyperinsulinemic hypoglycemia with nesidioblastosis: histologic features and growth factor expression. Mod Pathol. 2009 Feb; 22(2):239-45. Epub 2008 Oct 17.
    View PubMed
  49. Dalla Man C, Bock G, Giesler PD, Serra DB, Ligueros-Saylan M, Foley JE, Camilleri M, Toffolo G, Cobelli C, Rizza RA, Vella A. The effect of Dipeptidyl Peptidase 4 Inhibition on Insulin Secretion and Action in Type 2 Diabetes. Diabetes Care. Jan. 2009; 1(14-8).
  50. Dalla Man C, Bock G, Giesler PD, Serra DB, Ligueros Saylan M, Foley JE, Camilleri M, Toffolo G, Cobelli C, Rizza RA, Vella A. Dipeptidyl peptidase-4 inhibition by vildagliptin and the effect on insulin secretion and action in response to meal ingestion in type 2 diabetes. Diabetes Care. 2009 Jan; 32(1):14-8. Epub 2008 Oct 17.
    View PubMed
  51. Smushkin G, Vella A. Inhibition of dipeptidyl peptidase-4: The mechanisms of action and clinical use of vildagliptin for the management of type 2 diabetes. Diabetes Metab Syndr Obes. 2009; 2:83-90. Epub 2009 Jun 12.
    View PubMed
  52. Arruda-Olson AM, Patch RK 3rd, Leibson CL, Vella A, Frye RL, Weston SA, Killian JM, Roger VL. Effect of second-generation sulfonylureas on survival in patients with diabetes mellitus after myocardial infarction. Mayo Clin Proc. 2009; 84(1):28-33.
    View PubMed
  53. Vella A, Bock G, Giesler PD, Burton DB, Serra DB, Saylan ML, Deacon CF, Foley JE, Rizza RA, Camilleri M. The effect of dipeptidyl peptidase-4 inhibition on gastric volume, satiation and enteroendocrine secretion in type 2 diabetes: a double-blind, placebo-controlled crossover study. Clin Endocrinol (Oxf). 2008 Nov; 69(5):737-44. Epub 2008 Mar 10.
    View PubMed
  54. Roberts RO, Geda YE, Knopman DS, Christianson TJ, Pankratz VS, Boeve BF, Vella A, Rocca WA, Petersen RC. Association of duration and severity of diabetes mellitus with mild cognitive impairment. Arch Neurol. 2008 Aug; 65(8):1066-73.
    View PubMed
  55. Szarka LA, Camilleri M, Vella A, Burton D, Baxter K, Simonson J, Zinsmeister AR. A stable isotope breath test with a standard meal for abnormal gastric emptying of solids in the clinic and in research. Clin Gastroenterol Hepatol. 2008 Jun; 6(6):635-643.e1. Epub 2008 Apr 14.
    View PubMed
  56. Porterfield JR, Thompson GB, Young WF Jr, Chow JT, Fryrear RS, van Heerden JA, Farley DR, Atkinson JL, Meyer FB, Abboud CF, Nippoldt TB, Natt N, Erickson D, Vella A, Carpenter PC, Richards M, Carney JA, Larson D, Schleck C, Churchward M, Grant CS. Surgery for Cushing's syndrome: an historical review and recent ten-year experience. World J Surg. 2008 May; 32(5):659-77.
    View PubMed
  57. Young WF Jr, du Plessis H, Thompson GB, Grant CS, Farley DR, Richards ML, Erickson D, Vella A, Stanson AW, Carney JA, Abboud CF, Carpenter PC. The clinical conundrum of corticotropin-independent autonomous cortisol secretion in patients with bilateral adrenal masses. World J Surg. 2008 May; 32(5):856-62.
    View PubMed
  58. Vella A, Bouatia-Naji N, Heude B, Cooper JD, Lowe CE, Petry C, Ring SM, Dunger DB, Todd JA, Ong KK. Association analysis of the IGF1 gene with childhood growth, IGF-1 concentrations and type 1 diabetes. Diabetologia. 2008 May; 51(5):811-5. Epub 2008 Mar 04.
    View PubMed
  59. Atkinson JL, Young WF Jr, Meyer FB, Davis DH, Nippoldt TB, Erickson D, Vella A, Natt N, Abboud CF, Carpenter PC. Sublabial transseptal vs transnasal combined endoscopic microsurgery in patients with Cushing disease and MRI-depicted microadenomas. Mayo Clin Proc. 2008 May; 83(5):550-3.
    View PubMed
  60. Vella A, Camilleri M. Pharmacogenetics: potential role in the treatment of diabetes and obesity. Expert Opin Pharmacother. 2008 May; 9(7):1109-19.
    View PubMed
  61. Cooper JD, Smyth DJ, Bailey R, Payne F, Downes K, Godfrey LM, Masters J, Zeitels LR, Vella A, Walker NM, Todd JA. The candidate genes TAF5L, TCF7, PDCD1, IL6 and ICAM1 cannot be excluded from having effects in type 1 diabetes - art. no. 71. BMC Medical Genetics. 2007 Nov 28; 8:71.
    View PubMed
  62. Todd JA, Walker NM, Cooper JD, Smyth DJ, Downes K, Plagnol V, Bailey R, Nejentsev S, Field SF, Payne F, Lowe CE, Szeszko JS, Hafler JP, Zeitels L, Yang JH, Vella A, Nutland S, Stevens HE, Schuilenburg H, Coleman G, Maisuria M, Meadows W, Smink LJ, Healy B Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet. 2007 Jul; 39(7):857-64 Epub 2007 Jun 6.
    View PubMed
  63. Vella A, Bock G, Giesler PD, Burton DB, Serra DB, Saylan ML, Dunning BE, Foley JE, Rizza RA, Camilleri M. Effects of dipeptidyl peptidase-4 inhibition on gastrointestinal function, meal appearance, and glucose metabolism in type 2 diabetes. Diabetes. 2007 May; 56(5):1475-80. Epub 2007 Feb 15.
    View PubMed
  64. Dingli D, Wolf RC, Vella A. Imatinib and type 2 diabetes. Endocr Pract. 2007 Mar-Apr; 13(2):126-30.
    View PubMed
  65. Cooper JD, Smyth DJ, Bailey R, Payne F, Downes K, Godfrey LM, Masters J, Zeitels LR, Vella A, Walker NM, Todd JA. The candidate genes TAF5L, TCF7, PDCD1, IL6 and ICAM1 cannot be excluded from having effects in type 1 diabetes. BMC Med Genet. 2007; 8.
    View PubMed
  66. Ortu M, Vaccarezza M, Trovati S, Galli M, Gervasoni C, Vella A. A martial arts injury: karate induced unilateral haematoma of the adrenal gland. Br J Sports Med. 2006 Aug; 40(8):730-1; discussion 731. Epub 2006 May 24.
    View PubMed
  67. Morris GA, Lowe CE, Cooper JD, Payne F, Vella A, Godfrey L, Hulme JS, Walker NM, Healy BC, Lam AC, Lyons PA, Todd JA. Polymorphism discovery and association analyses of the interferon genes in type 1 diabetes. BMC Genet. 2006; 7:12. Epub 2006 Feb 22.
    View PubMed
  68. Smyth DJ, Howson JM, Payne F, Maier LM, Bailey R, Holland K, Lowe CE, Cooper JD, Hulme JS, Vella A, Dahlman I, Lam AC, Nutland S, Walker NM, Twells RC, Todd JA. Analysis of polymorphisms in 16 genes in type 1 diabetes that have been associated with other immune-mediated diseases. BMC Med Genet. 2006; 7:20. Epub 2006 Mar 06.
    View PubMed
  69. Vella A, Cooper JD, Lowe CE, Walker N, Nutland S, Widmer B, Jones R, Ring SM, McArdle W, Pembrey ME, Strachan DP, Dunger DB, Twells RC, Clayton DG, Todd JA. Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am J Hum Genet. 2005 May; 76(5):773-9.
  70. Stewart CE, Vella A. Acarbose in liver cirrhosis: cognitive or glycemic control? Clin Gastroenterol Hepatol. 2005 Feb; 3(2):108-9.
  71. Maier LM, Smyth DJ, Vella A, Payne F, Cooper JD, Pask R, Lowe C, Hulme J, Smink LJ, Fraser H, Moule C, Hunter KM, Chamberlain G, Walker N, Nutland S, Undlien DE, Ronningen KS, Guja C, Ionescu-Tirgoviste C, Savage DA, Strachan DP, Peterson LB, Todd JA, Construction and analysis of tag single nucleotide polymorphism maps for six human-mouse orthologous candidate genes in type 1 diabetes. BMC Genet. 2005; 6(1):9. Epub 2005 Feb 18.
    View PubMed
  72. Smyth D, Cooper JD, Collins JE, Heward JM, Franklyn JA, Howson JM, Vella A, Nutland S, Rance HE, Maier L, Barratt BJ, Guja C, Ionescu-Tirgoviste C, Savage DA, Dunger DB, Widmer B, Strachan DP, Ring SM, Walker N, Clayton DG, Twells RC, Gough SC, Todd JA. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes. 2004 Nov; 53(11):3020-3.
    View PubMed
  73. Vella A, Rizza RA. Extrapancreatic effects of GIP and GLP-1. Horm Metab Res. 2004 Nov-Dec; 36(11-12):830-6.
    View PubMed
  74. Vella A, Camilleri M, Rizza RA. The gastrointestinal tract and glucose tolerance. Curr Opin Clin Nutr Metab Care. 2004 Jul; 7(4):479-84.
    View PubMed
  75. Vella A, Howson JM, Barratt BJ, Twells RC, Rance HE, Nutland S, Tuomilehto-Wolf E, Tuomilehto J, Undlien DE, Ronningen KS, Guja C, Ionescu-Tirgoviste C, Savage DA, Todd JA. Lack of association of the Ala(45)Thr polymorphism and other common variants of the NeuroD gene with type 1 diabetes. Diabetes. 2004 Apr; 54(4):1158-61.
  76. Reed AS, Charkoudian N, Vella A, Shah P, Rizza RA, Joyner MJ. Forearm vascular control during acute hyperglycemia in healthy humans. Am J Physiol Endocrinol Metab. 2004 Mar; 286(3):E472-80. Epub 2003 Oct 28.
    View PubMed
  77. Eftychi C, Howson JM, Barratt BJ, Vella A, Payne F, Smyth DJ, Twells RC, Walker NM, Rance HE, Tuomilehto-Wolf E, Tuomilehto J, Undlien DE, Ronningen KS, Guja C, Ionescu-Tiirgoviste C, Savage DA, Todd JA. Analysis of the type 2 diabetes-associated single nucleotide polymorphisms in the genes IRS1, KCNJ11, and PPARG2 in type 1 diabetes. Diabetes. 2004 Mar; 53(3):870-3.
    View PubMed
  78. Adkins A, Basu R, Persson M, Dicke B, Shah P, Vella A, Schwenk WF, Rizza R. Higher insulin concentrations are required to suppress gluconeogenesis than glycogenolysis in nondiabetic humans. Diabetes. 2003 Sep; 52(9):2213-20.
    View PubMed
  79. Delgado-Aros S, Vella A, Camilleri M, Low PA, Burton DD, Thomforde GM, Stephens D. Effects of glucagon-like peptide-1 and feeding on gastric volumes in diabetes mellitus with cardio-vagal dysfunction. Neurogastroenterol Motil. 2003 Aug; 15(4):435-43.
    View PubMed
  80. Vella A, Reed AS, Charkoudian N, Shah P, Basu R, Basu A, Joyner MJ, Rizza RA. Glucose-induced suppression of endogenous glucose production: dynamic response to differing glucose profiles. Am J Physiol Endocrinol Metab. 2003 Jul; 285(1):E25-30. Epub 2003 Mar 11.
    View PubMed
  81. Vella A, Service FJ, O'Brien PC. Glucose counterregulatory hormones in the 72-hour fast. Endocr Pract. 2003 Mar-Apr; 9(2):115-8.
    View PubMed
  82. Shah P, Vella A, Basu A, Basu R, Adkins A, Schwenk WF, Johnson CM, Nair KS, Jensen MD, Rizza RA. Elevated free fatty acids impair glucose metabolism in women: decreased stimulation of muscle glucose uptake and suppression of splanchnic glucose production during combined hyperinsulinemia and hyperglycemia. Diabetes. 2003 Jan; 52(1):38-42.
    View PubMed
  83. Basu R, Di Camillo B, Toffolo G, Basu A, Shah P, Vella A, Rizza R, Cobelli C. Use of a novel triple-tracer approach to assess postprandial glucose metabolism. Am J Physiol Endocrinol Metab. 2003 Jan; 284(1):E55-69.
    View PubMed
  84. Kurtkaya-Yapicier O, Scheithauer BW, Carney JA, Kovacs K, Horvath E, Stratakis CA, Vidal S, Vella A, Young WF Jr, Atkinson JL, Lloyd RV, Kontogeorgos G. Pituitary adenoma in Carney complex: an immunohistochemical, ultrastructural, and immunoelectron microscopic study. Ultrastruct Pathol. 2002 Nov-Dec; 26(6):345-53.
    View PubMed
  85. Vella A, Shah P, Reed AS, Adkins AS, Basu R, Rizza RA. Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans. Diabetologia. 2002 Oct; 45(10):1410-5. Epub 2002 Sep 05.
    View PubMed
  86. Charkoudian N, Vella A, Reed AS, Minson CT, Shah P, Rizza RA, Joyner MJ. Cutaneous vascular function during acute hyperglycemia in healthy young adults. J Appl Physiol (1985). 2002 Oct; 93(4):1243-50.
    View PubMed
  87. Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk WF, Rizza RA. Effect of enteral vs. parenteral glucose delivery on initial splanchnic glucose uptake in nondiabetic humans. Am J Physiol Endocrinol Metab. 2002 Aug; 283(2):E259-66.
    View PubMed
  88. Vella A, Lee JS, Camilleri M, Szarka LA, Burton DD, Zinsmeister AR, Rizza RA, Klein PD. Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus. Neurogastroenterol Motil. 2002 Apr; 14(2):123-31.
    View PubMed
  89. Delgado-Aros S, Kim DY, Burton DD, Thomforde GM, Stephens D, Brinkmann BH, Vella A, Camilleri M. Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans. Am J Physiol Gastrointest Liver Physiol. 2002 Mar; 282(3):G424-31.
    View PubMed
  90. Shah P, Vella A, Basu A, Basu R, Adkins A, Schwenk WF, Johnson CM, Nair KS, Jensen MD, Rizza RA. Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans. Diabetes. 2002 Feb; 51(2):301-10.
    View PubMed
  91. Vella A, Pineda AA, O'Brien T. Low-density lipoprotein apheresis for the treatment of refractory hyperlipidemia. Mayo Clin Proc. 2001 Oct; 76(10):1039-46.
    View PubMed
  92. Vella A, Young WF. Pituitary apoplexy. Endocrinologist. 2001 Jul-Aug; 11(4):282-8.
    View PubMed
  93. Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk WF, Rizza RA. Type I diabetes mellitus does not alter initial splanchnic glucose extraction or hepatic UDP-glucose flux during enteral glucose administration. Diabetologia. 2001 Jun; 44(6):729-37.
    View PubMed
  94. Basu A, Basu R, Shah P, Vella A, Rizza RA, Jensen MD. Systemic and regional free fatty acid metabolism in type 2 diabetes. Am J Physiol Endocrinol Metab. 2001 Jun; 280(6):E1000-6.
    View PubMed
  95. Basu A, Basu R, Shah P, Vella A, Johnson CM, Jensen M, Nair KS, Schwenk WF, Rizza RA. Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity. Diabetes. 2001 Jun; 50(6):1351-62.
    View PubMed
  96. Vella A, Thompson GB, Grant CS, van Heerden JA, Farley DR, Young WF Jr. Laparoscopic adrenalectomy for adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab. 2001 Apr; 86(4):1596-9.
    View PubMed
  97. Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk FW, Holst JJ, Rizza RA. Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes. Diabetes. 2001 Mar; 50(3):565-72.
    View PubMed
  98. Vella A, Nippoldt TB, Morris JC 3rd. Adrenal hemorrhage: a 25-year experience at the Mayo Clinic. Mayo Clin Proc. 2001 Feb; 76(2):161-8.
    View PubMed
  99. Shah P, Vella A, Basu A, Basu R, Schwenk WF, Rizza RA. Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2000 Nov; 85(11):4053-9.
    View PubMed
  100. Samsom M, Szarka LA, Camilleri M, Vella A, Zinsmeister AR, Rizza RA. Pramlintide, an amylin analog, selectively delays gastric emptying: potential role of vagal inhibition. Am J Physiol Gastrointest Liver Physiol. 2000 Jun; 278(6):G946-51.
    View PubMed
  101. Vella A, Shah P, Basu R, Basu A, Holst JJ, Rizza RA. Effect of glucagon-like peptide 1(7-36) amide on glucose effectiveness and insulin action in people with type 2 diabetes. Diabetes. 2000 Apr; 49(4):611-7.
    View PubMed
  102. Basu A, Basu R, Shah P, Vella A, Johnson CM, Nair KS, Jensen MD, Schwenk WF, Rizza RA. Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. Diabetes. 2000 Feb; 49(2):272-83.
    View PubMed
  103. Vella A, Carlson LA, Blier B, Felty C, Kuiper JD, Rooke TW. Circulator boot therapy alters the natural history of ischemic limb ulceration. Vasc Med. 2000; 5(1):21-5.
    View PubMed
  104. Vella A, Gerber TC, Hayes DL, Reeder GS. Digoxin, hypercalcaemia, and cardiac conduction. Postgrad Med J. 1999 Sep; 75(887):554-6.
    View PubMed
  105. Vella A, McPhail I, Litin S. Unilateral proptosis in a 74-year-old woman. Adv Exp Med Biol. 1999; 455:529-33.
    View PubMed
  106. Vella A, Farrugia G. D-lactic acidosis: pathologic consequence of saprophytism. Mayo Clin Proc. 1998 May; 73(5):451-6.
    View PubMed
  107. Vella A, McPhail IR, Litin SC. 74-year-old woman with cough and proptosis. Mayo Clin Proc. 1997 Jun; 72(6):575-8.
    View PubMed
  108. Vella A, Farrugia G. 90-year-old man with fever and melena (translated into Polish). Medycyna Prakyczna. 1997 May.
  109. Vella A, Farrugia G. 90-year-old man with fever and melena. Mayo Clin Proc. 1996 Dec; 71(12):1205-8.
    View PubMed